HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jana Tuková Selected Research

Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)

10/2010677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jana Tuková Research Topics

Disease

2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2010 - 04/2009

Drug/Important Bio-Agent (IBA)

2Methotrexate (Mexate)FDA LinkGeneric
10/2010 - 04/2009
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
10/2010

Therapy/Procedure

1Drug Therapy (Chemotherapy)
04/2009